(Q40369503)

19 September 2017

title

Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs (English)

1 reference

Simian immunodeficiency virus

19 September 2017

0 references

0 references

5

Ayalew Mergia

1 reference

19 September 2017

2

Peter Nadeau

1 reference

19 September 2017

Jeonghae Park

1

1 reference

19 September 2017

James R Zucali

series ordinal

3

1 reference

19 September 2017

Calvin M Johnson

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

21 September 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

343

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

275-282

1 reference

Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Identification of a human population infected with simian foamy viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Properties of human foamy virus relevant to its development as a vector for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Why aren't foamy viruses pathogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Clinical research. Gene therapy a suspect in leukemia-like disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Gene therapy. Second child in French trial is found to have leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Replication and regulation of primate foamy viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Cell tropism of the simian foamy virus type 1 (SFV-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

A minimal genome simian foamy virus type 1 vector system with efficient gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Cell-cycle dependence of foamy virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Effective expression of small interfering RNA in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Foamy retroviruses. A virus in search of a disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Naturally acquired simian retrovirus infections in central African hunters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.038

10.1016/J.VIROL.2005.08.038

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference